Visiongain Ltd.

Visiongain is proud to announce the release of the brand new report "Ophthalmic Pharmaceuticals Market ". The global market for ophthalmic pharma is a large and profitable segment of the healthcare market, with ophthalmic sales of over $10bn in 2007.

Visiongain is proud to announce the release of the brand new report "Smoking Cessation Report".Smoking is the leading cause of preventable death in the world. The effects of smoking represent a global pandemic of enormous proportions.

Visiongain is proud to announce the release of the brand new report "World diabetes Market Analysis". The WHO estimates the number of diabetics to exceed 350 million by 2030.

Visiongain is proud to announce the release of the brand new report "Inflammatory Bowel Diseases". The world market for intestinal anti-inflammatories was worth over $2400 million in 2008, and had grown at 9% over the previous year.

Visiongain is proud to announce the release of the brand new report "Statins: The World Market" The world statins market is changing, with patent expires and maturity of the landmark product Lipitor (atorvastatin).

Visiongain is proud to announce the release of the brand new report "Anti-Obesity Treatments Analysis" Obesity has been described as a 'public health time-bomb'. In 2005, the WHO estimated that approximately 400 mln. individuals are obese.